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Systemic lupus erythematosus patients produce 
a broad spectrum of autoantibodies (auto-Abs), 
including anti–double-stranded (ds)DNA (1, 2). 
In healthy individuals these auto-Abs are reg-
ulated at multiple checkpoints during B cell 
  development (3, 4), and defects, such as loss of 
T cell tolerance (5), late-stage B cell deregula-
tion (6), and clearance defects of nuclear and cy-
toplasmic antigens, can lead to autoimmunity.
A reproducible appearance of auto-Abs can 
be achieved by induction of a systemic lupus 
erythematosus–like syndrome by a chronic 
graft-versus-host (cGvH) reaction (7). To ini-
tiate cGvH, lymphocytes from a Bm-12 mouse 
are transferred into a C57BL/6 (B6) recipient 
(8, 9). The Bm-12 and the B6 mouse diff  er at 
the MHC class II protein by three amino acids; 
hence, the cGvH is thought to be mediated by 
Bm-12 CD4+ T cells (10). cGvH leads to B cell 
hyperactivation followed by the production of 
a variety of auto-Abs directed to chromatin, 
Sm, DNA, and other nuclear antigens. In ad-
dition, the mice develop glomerulonephritis 
(8, 11). The cGvH is thought to require B cell 
receptor cross-linking (12). The spectrum of 
auto-Abs induced by cGvH is narrowed in an 
anti-DNA transgenic mouse, referred to as 
56R/B6 (13–15). This 56R H chain site-
  directed knock-in mouse was generated using 
the VH from an anti-DNA Ab isolated from a 
diseased MRL/lpr mouse (16). The DNA re-
activity of the 56R H chain is due to positive 
charges of arginines (Args) in the complemen-
tarity-determining regions (CDRs) (17).
The 3H9 and 56R transgenic models have 
been useful for studying the mechanism of re-
ceptor editing (18, 19). L chain rearrangement 
in the 56R model seems to persist until the 
self-reactivity of the transgenic 56R H chain is 
altered. Such B cells bearing the 56R trans-
genic H chain are allowed to migrate into the 
periphery when paired with so called “editor” 
L chains. Such editor L chains have low iso-
electric points due to a high frequency of as-
partates (Asps) in their CDRs, and we think 
they block the interaction between H chain 
Arg and DNA (17).
The 56R H chain on a BALB/c back-
ground pairs mainly with the κ L chain Vκ21D, 
an effi   cient editor of anti-DNA activity (17). 
On a B6 background, however, less effi   cient 
editors Vκ38C and Vκ20 L chains are used (17, 
20, and unpublished data). Among λ chains, λx 
has been shown to modify DNA binding of the 
56R H chain (21, 22) and may result in   altered 
self-reactivity. In 56R/BALB/c mice, a new 
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population of edited 56R H chain transgenic B cells has been 
identifi  ed. In this mouse, B cells express two receptors of 
which one is κ and the other is λ1 (17), and these “partially 
edited” B cells are thought to reside in the marginal zone 
(MZ) (23, 24).
Using cGvH, we asked whether incompletely and par-
tially edited B cells were activated and secreted auto-Abs in 
cGvH. We fi   nd that the induction of anti-DNA Abs is 
  accompanied by the induction of other auto-specifi  cities. 
Hybridoma panels derived from cGvH-induced mice were 
analyzed and showed that auto-Abs arose from B cells that 
were polyreactive and bound to self-antigens and proteins, 
such as dsDNA, phosphatidylserine (PS), myelin basic protein 
(MBP), thyroglobulin, histone, insulin, cytochrome C, and 
β-galactosidase. We found that the observed polyreactivity 
was a feature of the 56R H chain in combination with the 
editor L chains Vκ20 and Vκ38C. Consistent with the ex-
pression of both the κ and λ L chain in the serum after cGvH 
disease, hybridoma panels derived from cGvH-induced mice 
included partially edited B cells with λ1 L chain that coex-
pressed κ L chain. The B cells with the λ and κ L chain 
bound to dsDNA, MBP, and PS and could account for some 
of the auto-Ab expression in cGvH. In addition, those dou-
ble positive B cells may be located in the MZ.
RESULTS
Induction of auto-Abs in cGvH
The cGvH reaction induces a lupus-like syndrome that in-
cludes activated lymphocytes and the production of auto-
Abs (8, 9). In previous studies, cGvH was induced by the 
transfer of splenocytes (7–11, 14, 15, 25, 26) or partially 
purifi  ed CD4+ T cells (27) from Bm-12 mice to B6 recipi-
ents. The cGvH induces a variety of auto-Abs in B6 mice 
(8, 10), but in the case of 56R/B6, the auto-Ab repertoire 
is enriched in anti-DNA specifi  cities as has been observed 
in studies on 56R Abs from unmanipulated and cGvH 
56R/B6 mice (13–15, 28). To rule out possible donor B 
cell response in the cGvH, we used purifi  ed Bm-12 CD4+ 
T cells (CD4+CD3+ > 96%; not depicted). Under these 
conditions, we found that cGvH caused an increase of anti-
dsDNA Abs (Fig. 1 A), accompanied by an increase of anti-
PS Abs (Fig. 1 B), but we also fi  nd induction of anti-MBP 
Abs (Fig. 1 C).
The cGvH also activated peripheral B cells in the 56R/B6 
recipient as seen by the transient expression of CD69 and 
CD86 as well as by the increased levels of MHC class II and 
Fas (CD95). A slight decrease of CD24 was also observed 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20060075/DC1). We conclude that cGvH induced by 
purifi  ed CD4+ T cells leads to secretion of anti-DNA Ab 
and activation of B cells in the 56R/B6 recipient. The in-
duction of diff  erent auto-Ab specifi  cities in 56R transgenic 
mice raised the following questions: Do these specifi  cities 
come from diff  erent nontransgenic B cell populations, or can 
these specifi  cities be attributed to polyreactive Abs expressed 
by 56R H chain with editor L chains as has been found to be 
the case for Vκ20 and Vκ38C? The 56R transgene in B6 
mice both accelerates the onset and increases the titers of 
anti-dsDNA Abs in cGvH as reported previously (14, 15). 
To study the role of 56R in auto-Ab induction, we tested 
the expression of 56R H chain by fl  ow cytometry and in 
  hybridoma panels. 
Role of 56R H chain in auto-Ab induction
To test whether the anti-DNA, anti-PS, and anti-MBP Ab 
specifi  cities (Fig. 1) were associated with the 56R H chain, 
we used allotype-specifi  c Abs that distinguish the transgenic 
allele Igha (16, 29) and the nontransgenic endogenous allele 
Figure 1.  cGvH leads to the concomitant induction of anti-dsDNA, 
anti-PS, and anti-MBP Abs in 56R H chain transgenic mice. For in-
duction of cGvH, Bm12 CD4+ T cells were injected into 56R/B6 (■). As a 
control, B6 CD4+ T cells were injected into 56R/B6 (△). Anti-DNA, anti-PS, 
and anti-MBP Abs in sera were tested at the indicated time points by ELISA 
at a serum dilution of 1:180. IgM and IgG Abs to dsDNA (n = 6 for con-
trol group and n = 7 for cGvH group) (A), to PS (n = 5 for control and cGvH 
group) (B), and to MBP (n = 3 for control group and n = 6 for cGvH 
group) (C) were tested by ELISA. MRL/lpr sera were tested at the same con-
centration for comparison (●; n = 4). Results represent means ± SEM.JEM VOL. 203, July 10, 2006  1763
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Ighb of the 56R/B6 mouse. In the control mice, 45–48% of 
the B220+ splenic B cells were IgMa+ and IgDa+ at day 60. 
An almost identical number (44–45%) was found in the 
cGvH group. Of the B220+ B cells, 8–10% expressed endog-
enous H chain according to allotype IgMb and IgDb expres-
sion. This may result from aberrant VH replacement followed 
by rearrangement of the untargeted allele. The IgMb and 
IgDb fraction did not change after cGvH (Fig. S2 A, available 
at http://www.jem.org/cgi/content/full/jem.20060075/
DC1). From the correlation of allotype expression and auto-
Ab production, we conclude that 56R H chain is mainly 
  associated with the cGvH-induced auto-Abs.
mAbs isolated after cGvH
To test whether κ-edited 56R Abs are responsible for the dif-
ferent autoreactivities found in the serum (Fig. 1), we studied 
mAbs secreted by the hybridomas in two independent fusion 
panels generated 4 and 10 wk after cGvH. We tested the hy-
bridomas for several characteristics: binding to multiple self-
antigens, the H chain isotype, and the type of L chains.
Specifi  city and isotype. In the 4-wk fusion, 53 out of 78 
hybridomas secreted IgM or IgG (Table I A and Table S1, 
which is available at http://www.jem.org/cgi/content/full/
jem.20060075/DC1). Similar results were obtained in the 
10-wk fusion, as 42 out of 139 hybridomas secreted IgM 
(  Table S2). Both fusions yielded a large number of clones that 
were IgM–IgG–. These “nonsecretors” were not analyzed 
further. Supernatants from both fusions were tested for bind-
ing to dsDNA, PS, and MBP. Most of the mAbs in the 4-wk 
fusion bound dsDNA as well as PS. In addition, these mAbs 
bound MBP (Table I A). Polyreactive mAbs that bound to 
dsDNA, PS, and MBP were also found in the 10-wk fusion 
(see below; Table II).
H chain gene usage in polyreactive Abs. To determine 
whether these polyreactive mAbs were associated with 56R, 
we tested whether the hybridomas have an intact 56R gene. 
PCR products from primers complementary to the 3H9/56R 
(56R) H chain leader sequence and the CDR3 of the 56R 
transgene (16) indicate the presence of the complete 
56R transgene. In the 4-wk fusion, we found 33 clones out 
of 53 secretors to be 56R+ (Table I A). The remaining 
20 clones did not amplify the 56R transgene by this assay and 
are classifi  ed as 56R–. 11 of these 20 56R– clones did amplify 
a product with a 56R CDR3 reverse primer and the JHCH 
primer. This PCR product represents 56R VH genes that 
have been truncated or VH replaced (13). No PCR product was 
detected with either of the 56R PCRs in 9 out of 20 56R– 
clones, and they were not analyzed further (Table S1).
Most of the clones that bound dsDNA, PS, and MBP 
were 56R+ (Table I A). A few 56R– clones bound to PS, 
  dsDNA, and MBP, but their affi   nity for these antigens rela-
tive to the 56R+ mAbs was low (Table S1).
L chain gene usage. We determined the types of L chains of 
these polyreactive mAbs. The Vκ genes from both the 56R+ 
group and the 11 56R– mAbs that have truncated or VH 
Table I.  B cell hybridomas generated from 56R/B6 
splenocytes 4 wk after cGvH reaction
A
Total clones 
(78)
56R tg+ 
(33)
IgM+ (29) 24
Reactivity to
 dsDNA 23
 PS 18
 MBP 21
IgG+ (24) 9
Reactivity to
 dsDNA 3
 PS 2
 MBP 3
B
Total clones
(36)
Vκ12-13
(3)
Vκ20
(10)
Vκ21D
(4)
Vκ38C
(8)
Vκ(S)
(17)
56R tg+ (25)
1(J2)a 
2(J5)a
3(J2)a 
5(J4)a 4(J2)a 1(J2) 1(J4) 
4(J5)a 9
56R tg–b (11) 2(J5)a 1(J2)a 
1(J4)
8
56R+ clones from fusion 4 wk after cGvH (Bm-12 into 56R/B6) are polyreactive (A). 
κ L chain usage in 56R+ and 56R– clones from fusion 4 wk after cGvH (Bm-12 into 
56R/B6). Only clones with H and L chain secretion are listed and were tested for 
rearrangement of κ L chains using specifi  c primers for Vκ12-13, Vκ20, Vκ21D, and 
Vκ38C, and a degenerate primer Vκ(S) for other κ rearrangements (B). For more 
details see Table S1.
aGroups that contain clones with two L chain rearrangements.
b56R H chain transgenic–/CDR3JHCH+.
J, Jκ gene in rearrangement.
Table II.  Binding of MBP and PS of 56R+IgM+ B cell 
hybridomas with different L chains
A
Vκ-gene MBP/dsDNA binding PS/dsDNA binding
Vκ20/J2 0.77 ± 0.10 (n = 7) 5.55 ± 1.78 (n = 3)
Vκ20/J4 0.58 ± 0.05 (n = 14) 3.62 ± 1.02 (n = 6)
Vκ38c/J2 0.61 ± 0.09 (n = 7) 0.40 ± 0.12 (n = 3)
Vκ38c/J4 0.92 ± 0.06 (n = 7) 0.51 ± 0.27 (n = 3)
Vκ38c/J5 0.35 ± 0.03 (n = 11) 1.06 ± 0.24 (n = 4)
Vκ(S)/J1 1.03 ± 0.07 (n = 7) 0.25 ± 0.02 (n = 3)
B
Vκ-gene MBP/dsDNA binding PS/dsDNA binding 
Vκ20/J2 1.46 ± 0.05 (n = 3) 14.26 ± 0.85 (n = 3)
Vκ20/J4 0.85 ± 0.08 (n = 7) 10.68 ± 2.41 (n = 7)
Vκ38c/J5 1.36 ± 0.14 (n = 3) 1.25 ± 0.06 (n = 3)
56R+ IgM hybridomas are compared from two fusions. Clones were polyreactive to at 
least two antigens in ELISA assays testing for dsDNA, PS, and MBP. The mean of the 
MBP/dsDNA and PS/dsDNA was calculated from at least three clones, and ± indicates 
the error (SEM). The values show the binding to PS and MBP relative to DNA binding. 
Fusion panels are from 4 (A) and 10 wk (B) after GvH. For more details see Table S2.1764  CHRONIC GRAFT-VERSUS-HOST REACTION INDUCES POLYREACTIVE ANTIBODIES | Witsch et al.
  replaced the 56R gene were identifi  ed by PCR using primers 
specifi  c for the editors Vκ12−13, Vκ20, Vκ21D, and Vκ38C 
(Table I B) (17). Other Vκ rearrangements were detected us-
ing a degenerate Vκ primer, Vκ(S) or the L5 primer. Jκ was 
also determined. Most clones with the 56R H chain had re-
arranged the L chain editors Vκ12–13, Vκ20, Vκ21D, and 
Vκ38C to Jκ4 or Jκ5 (15 rearrangements) and slightly less to 
Jκ1 or Jκ2 (10 rearrangements). Some clones in the 56R+ 
and 56R– group had more than one editor rearrangement 
(marked with an asterisk in Table I B). Editor L chains were 
more abundant in the 56R+ group, and Vk20 and Vk38C 
were rearranged more often than Vk21D as has been shown 
for 56R/B6 (20 and unpublished data). This is a diff  erent 
distribution than in 56R/BALB/c, where Vκ21D is the pre-
dominant editor (17, 20). We think this may be related to the 
susceptibility to autoimmunity of 56R/B6 mice (30–34).
Contribution of L chain to polyreactivity
The 56R+ mAbs had distinguishable reactivities depending 
on the Vκ and Vκ/Jκ combination. Vκ21D vetoed binding 
to dsDNA and the other antigens: PS, MBP, thyroglobulin, 
cytochrome C, histone, β-galactosidase, and insulin. Both 
Vκ20 and Vκ38C Abs were polyreactive, but their binding 
pattern was diff  erent (Fig. 2 A). 56R+ clones with Vκ20 or 
Vκ38C bound dsDNA with higher relative affi   nity  than 
Vκ21D. In addition, Vκ20 and Vκ38C rearranged to J2 
bound dsDNA with a higher relative affi   nity than the same 
V regions rearranged to J4 or J5 (Fig. 2 A). We studied the 
binding to PS, MBP, and the other proteins relative to their 
binding to dsDNA. We showed that binding to PS was fa-
vored over binding to dsDNA in clones with the L chain 
Vκ20, whereas Vκ38C L chains bound to dsDNA and PS 
with similar affi   nity. Affi   nity for MBP, thyroglobulin, cyto-
chrome C, histone, and β-galactosidase was higher in Vκ38C 
as compared with Vκ20, and no diff   erence was found 
  between Vκ20 and Vκ38C for insulin (Fig. 2 B).
Relative binding to PS and MBP was also assessed by cal-
culating the ratios of PS to DNA and MBP to DNA binding 
of the mAbs that expressed the 56R transgene from clones in 
both fusions. Again, PS/dsDNA binding relative to MBP/ 
dsDNA binding was greater in clones that expressed the 
Vκ20 as compared with the Vκ38C L chain, whereas binding 
to PS/dsDNA and to MBP/dsDNA was similar in clones that 
expressed the Vκ38C L chain (Table II).
Plasma cell differentiation in cGvH
We searched for the origin of polyreactivity by fl  ow cytome-
try. After cGvH induction, there was an increase in B220+IgG+ 
splenocytes expressing the plasma cell marker CD138 (2.57 
and 4.05% of the B220+ cells by days 28 and 60 after cGvH, 
respectively). We considered these surface Ig–expressing B 
cells to be pre-plasma cells (Fig. 3 A). We also found an in-
crease of B220+IgMa+ B cells expressing CD138 (0.37 and 
0.75% of the B220+ cells by days 28 and 60 after cGvH, 
  respectively), indicating that B cells with the H chain  transgenic 
allele Igha of the 56R/B6 mouse diff  erentiated into plasma 
cells, and were giving rise to anti-DNA Abs. B220+IgMa– B 
cells expressing CD138 (2.29 and 2.95% of the B220+ cells by 
days 28 and 60 after cGvH, respectively) were also increased 
and most likely to be of the IgG class (Fig. S2 B).
Figure 2.  Subclones from selected 56R+ hybridomas from the 
fusion 4 wk after cGvH induction were tested for binding to dsDNA, 
PS, and the proteins MBP, thyroglobulin, cytochrome C, histone, 
𝗃-galactosidase, and insulin by ELISA. The OD405 of the binding assays 
was normalized based on the Ig concentration of 1 μg/ml for each super-
natant. All clones were IgM+ and expressed the indicated editor L chain. 
The following groups were tested: Vκ20/J2: n = 2 (clones 50.1 and 50.2 
from one original clone); Vκ20/J4: n = 4 (clones 71.1, 71.5, 73.2, and 73.4 
from two original clones); Vκ21D/J2: n = 2 (clones 79.1 and 79.5 from 
one original clone); Vκ38C/J2: n = 2 (clones 160.1 and 160.5 from one 
original clone); Vκ38C/J4: n = 2 (clones 222.4 and 222.6 from one 
 original  clone);  Vκ38C/J5: n = 3 (clones 89.4, 89.6 and 105.5 from 
two original clones); and Vκ(S)/J1: n = 2 (clones 206.1 and 206.5 from 
one original clone). All clones tested were sequenced using specifi  c prim-
ers for Vκ20, Vκ21D, and Vκ38C and were unmutated. All tested binding 
specifi  cities are shown in comparison for one representative result for 
each group. SEM from triple values in the ELISA assay (A). To analyze the 
binding of the subclones (to PS and the proteins MBP, thyroglobulin, 
histone, insulin, cytochrome C, and β-galactosidase) relative to dsDNA 
binding, dsDNA binding of each subclone was set to 1; therefore, only 
clones with considerable binding to dsDNA were included in this repre-
sentation. Relative binding to the tested antigens is shown for clones 
using the indicated L chain. Numbers show p-values determined by the 
Anova Single Factor Test (B).JEM VOL. 203, July 10, 2006  1765
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Potentially pathogenic auto-Abs are thought to home to 
the MZ (35, 36); therefore, we tested whether MZ B cells 
were aff  ected by cGvH in the 56R/B6. This is relevant be-
cause it has been shown that 56R/BALB/c has an enlarged 
MZ B cell compartment. Here we show that in the 56R/B6, 
the MZ B cell population (CD21high and CD23low) com-
prised as much as 50% of the B220+ splenocytes. The per-
centage of the MZ B cell population decreased after cGvH, 
whereas the CD21–CD23– B cell population increased. The 
percentage of follicular B cells (CD21intCD23high) slightly 
increased (Fig. 3 B, dot plots). The majority of the CD138+ 
B cells was found in a subpopulation of CD21–CD23– B 
cells (Fig. 3 B, histograms). Yet, during cGvH, the number 
of lymphocytes in the spleen increased on average 2.5-fold 
and the spleen weight increased 3.2-fold (not depicted); 
therefore, we cannot conclude that the absolute numbers 
of  MZ B cells in cGvH were decreasing. However, we 
  observed a decrease of CD21 expression by the mean fl  uo-
rescence intensity on MZ B cells (not depicted). This sug-
gests that MZ B cells were activated during cGvH. The 
concommitant increase of plasma cell diff  erentiation and the 
decrease of CD21 expression in MZ B cells suggest that 
  potentially autoreactive B cells from the MZ were aff  ected 
by the cGvH reaction and may have diff  erentiated to  become 
auto-Ab–producing B cells.
Figure 3.  cGvH induces differentiation of plasma cells and the 
redistribution of MZ and follicular B cells in the spleen of 56R/B6 
mice. The plasma cell marker CD138 was increased on a small population 
of B220+ splenocytes in the IgG+ B cell population 28 and 60 d after 
cGvH. 56R/B6 mice were injected with Bm-12 CD4+ T cells (cGvH mice) or 
injected with B6 CD4+ T cells (control mice). Results are representative of 
four experiments (A). The percentage of MZ B cells (CD21high and CD23low) 
was decreased after cGvH, and the percentages of CD21–CD23– B cells 
and the follicular B cells (CD21intCD23high) were increased (dot plots). 
CD21–CD23– B cells show an increase of CD138 by days 14 and 60 after 
cGvH (black line, histograms) as compared with control recipients (gray 
line, histograms). One representative experiment out of six is shown (B). 
B cells expressing κ and λ L chain were found among B220+ B cells in the 
spleen. The decreasing percentage of κ/λ double positive B cells may be 
due to the increase in total lymphocyte numbers in cGvH. One experiment 
out of three is shown (C).
Figure 4.  cGvH induces long-lasting activation of T cells in spleno-
cytes of 56R mice. Expression of CD4, CD69, and the T cell costimula-
tory molecules CD28 and ICOS is shown on CD3+ T cells, and the expression 
of CD44 and CD45RB is shown on CD4+ T cells (dot plots). The levels of 
CD62L on CD4+ T cells (histograms) were decreased after cGvH (black line) 
as compared to the control (gray line) at days 14 and 60. One representative 
experiment out of fi  ve is shown.1766  CHRONIC GRAFT-VERSUS-HOST REACTION INDUCES POLYREACTIVE ANTIBODIES | Witsch et al.
T cells in the spleen of 56R/B6 recipients were also acti-
vated as seen by the down-regulation of CD3 (not depicted) 
and CD4 as well as by the increased expression of CD69 
(tested at day 14; Fig. 4). The expression of the T cell co-
stimulatory molecules CD28 and ICOS also increased, and 
CD4+ T cells displayed a memory phenotype as shown 
by the expression of CD44high, CD45RBlow, and CD62Llow 
(Fig. 4). We could not distinguish between donor and recip-
ient CD4+ T cells in these studies, but the activation of 
T cells as late as day 60, by which time we would not expect 
Bm-12 donor T cells, indicates a role of endogenous T cells 
in antigen activation. We conclude from these data that 
cGvH induced by purifi  ed Bm-12 CD4+ T cells leads to 
plasma cell diff  erentiation (Fig. 3) and a sustained activation 
profi  le of T cells in the 56R/B6 recipient (Fig. 4). The role 
of endogenous T cells in the cGvH has been established by 
studies showing that CD4 knockout mice are unresponsive 
to cGvH (37).
Expression of 𝗌 L chain in cGvH
We tested anti-DNA Abs for the usage of κ and λ L chain in 
the serum after cGvH and developed our anti-dsDNA assay 
with anti-λ and anti-κ reagents. We found λ- and κ-contain-
ing anti-dsDNA Abs (Fig. 5 A). The strong induction of λ 
anti-dsDNA Abs led us to ask whether these Abs come from 
isotypically included B cells that express λ1 and κ L chain 
(18). We also asked whether these isotypically included 
B cells are activated by cGvH and diff  erentiate into anti-
  dsDNA–producing plasma cells. This is relevant because it 
has been shown that MZ B cells in the 56R/BALB/c mouse 
can coexpress a κ and a λ L chain. The λ1 L chain with 56R 
H chain binds DNA (38), but the κ L chain is an editor (17). 
These isotypically included B cells are thought to be seques-
tered in the MZ (23, 24). We analyzed the composition of 
B cells in the MZ of a 56R/B6 mouse using a single cell PCR 
technique and tested for B cells with both λ1 and κ L chain 
(Table III, A and B). L chain rearrangements were identifi  ed 
Figure 5.  𝗌 and 𝗋 L chain usage in anti-dsDNA Abs in 56R/B6 
after cGvH. For induction of cGvH, Bm-12 CD4+ T cells were injected 
into 56R/B6 (■). As a control, B6 CD4+ T cells were injected into 56R/B6 
(△). Anti-DNA Abs were detected by ELISA with an anti-λ (n = 6 for 
cGvH group and n = 3 for control group) and anti-κ (n = 4 for cGvH 
group and n = 3 for control group) detection Ab by ELISA at a serum 
dilution of 1:180. Results represent means ± SEM. MRL/lpr sera were 
tested for comparison (●; n = 4) (A). Detection of L chain expression 
during cGvH in serum was analyzed by Western blot. Sera from mice 
after cGvH (Bm-12 CD4+ T cells injected into B6 or 56R/B6 recipients) 
or sera from control mice (B6 CD4+ T cells were injected into B6 or 
56R/B6 recipients) were run under reducing conditions. λx was de-
tected using a polyclonal anti-Vλx Ab (reference 22). Serum samples 
were diluted at 1:100 for λ and at 1:2,000 for κ L chain detection. The 
expression of λx after exposure for 5 min, λ1,2,3 after exposure for 20 
min, and κ after exposure for 30 s is shown. Results are representative 
of seven experiments. λx, λ1,2,3 and κ in the serum are shown from 
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using nested PCRs on cDNA from single cells. Specifi  c 
primers were used for Vλ1/2 and Cλ1/2, Vκ21D and Cκ, 
and Vκ38C and Cκ (20). Other κ L chains were amplifi  ed 
using the degenerate primer Vκ(S) (39). We found that all 
B cells with λ L chain also had a κ L chain rearrangement. 
Sequence analysis showed that B cells with in-frame λ1 L chain 
had rearranged the editor L chain Vk21D and Vk38C. Two 
examples with in-frame λ1 L chain had, in addition to the 
κ editor, another κ rearrangement. Other λ L chain PCR 
products had large deletions in the V or V/J regions. Rear-
rangement of λ L chain in-frame or out of frame was always 
accompanied by an in-frame κ L chain that was often the 
  editor Vκ38C or Vκ20 (Table III B). Thus, the MZ contains 
a population of B cells that seems to have rearranged exces-
sively and introduced λ deletions.
We tested whether κ/λ1 56R B cells were activated by 
cGvH by analysis of a fusion panel 10 wk after cGvH. We 
found isotypically “included” B cells that coexpressed a λ1 
Table III.  Single cell analysis of B cells from the MZ of a 56R/B6 mouse
A
Single cells (179) 56R tg+ (124) Vκ(S) (124) Vκ38C (100) Vκ21D Vλ (26)
 Plate  I 67 80 30 11 15
 Plate  II 57 44 70 n.d. 11
56R tg+ (124) Vκ (S) (87) Vκ38C (64) Vκ21D Vλ (17)
 Plate  I 58 29 10 9
 Plate  II 29 35 n.d. 8
B
Cell no. 56R Vκ(S)/Cκ Vκ38C/Cκ Vκ21D/Cκ Vλ1/Cλ
Plate I
 10 + +a
 18 +a
 20 + (Vκ21-4 (98%)/J2 (100%) IF) +b (IF)
 22 +++ a
 40 + + 
 43 ++ +  
 53 ++  (V𝗋kk4 (91%)/J5 (95%) IF) + (V𝗋38C/J5 IF) + (V𝗌1/J𝗌1/C𝗌1 IF)
 59 ++ +a
 62 ++ +  (Vκ38C/J4 IF) + (Vλ1/Jλ3/Cλ2 OF)
 63 ++  (Vκ21-4 (98%)/J2 (100%) IF) + (Vκ38C/J5 IF) + (Vλ1/Jλ1/Cλ1 OF)
 74 + + (Vλ2/Jλ2/Cλ2 OF)
 75 + (Vκ21-4 (98%)/J1 (100%) IF) ++  (n.d.)
 76 ++ + a
 95 ++ + (Vλ1/Jλ1/Cλ1 OF)
Plate II
 13 + (V𝗋21-4 (98%)/J2 (100%) IF) n.d. + (V𝗌1/J𝗌1/C𝗌1 IF)
 14 ++  (Vκ19-23 (98%)/J5 (100%) IF) n.d. + (Vλ1/Jλ1/Cλ1 OF)
 29 ++  (Vκ21-4%) (98)/J2 (97%) IF) n.d. + (Vλ1/Jλ3/Cλ? OF)
 33 ++  (Vκ19-15 (92%)/J5 (100%) OF) + (Vκ38C/J4 IF) n.d. + (Vλ1/Jλ3/Cλ2 OF)
 34 ++  (Vκ38C/J4 IF) n.d. +
 49 ++  (Vκ38C/J5 IF) n.d. + (Vλ1/Jλ1/Cλ1 OF)
 52 ++  (Vκ19-23 (98%)/J2 (100%) IF) n.d. + (Vλ1/Jλ1/Cλ1 OF)
 59 ++  (Vκ21-4 (98%)/J2 (96%) IF) + (Vκ38C/J4 IF) n.d. +a (Vλ1)
 60 + (V𝗋kk4 (99%)/J5 (100%) IF) + (V𝗋38C/J4 IF) n.d. + (V𝗌1/J𝗌1/C𝗌1 IF)
 71 ++  (Vκ19-23 (97%)/J2 (100%) IF) + (Vκ38C/J4 IF) n.d. +
Single cells from the MZ (B220+CD21high and CD23low) in a 56R/B6 mouse were analyzed by PCR for Igκ, Igλ, and 56R H chain. All PCR product-positive cells were included in 
the table (A). B cells contained Igλ+ cells. B cells with in-frame λ L chain show message for one or two in-frame κ L chain(s) (in bold) (B). For further details see Table S3. 
Numbers in parentheses indicate sequence similarity to the germline gene in percentages.
n.d., not done.
IF, in frame.
OF, out of frame.
%, sequence similarity in percent, determined for κ L chains amplifi  ed with the degenerate primer V κ (S).
aDeleterious events in V and J.
bDeleterious events in V.1768  CHRONIC GRAFT-VERSUS-HOST REACTION INDUCES POLYREACTIVE ANTIBODIES | Witsch et al.
and a κ L chain. 5 out of 139 clones were λ1, and 4 of these 
expressed the 56R H chain. One λ1 clone did not express 
the 56R H chain and was negative for IgM and IgG. All of 
the 56R/λ1-expressing clones coexpressed a κ L chain by 
ELISA, and in three of those examples, we found rearrange-
ment of λx by PCR. In addition, we found one clone that 
expressed the 56R H chain with λ2. All clones that expressed 
the 56R H chain with λ1/κ or λ2 L chain bound to dsDNA, 
PS, and MBP. None of the clones expressed only λ1, indicat-
ing that B cells that express the 56R H chain with λ1 alone 
are eliminated from the repertoire (Table IV). Thus, partially 
edited B cells coexpressing λ and κ L chain were activated in 
cGvH and could be fused. We also found κ/λ-expressing 
B cells from cGvH-induced mice by fl  ow cytometry (Fig. 3 C); 
however, the number of isotypically included B cells was 
higher as found by single cell PCR analysis (Table III). We 
are considering that this phenomenon is due to the slight 
cross-reactivity of anti-λ and anti-κ Abs used in fl  ow cytom-
etry analysis (Fig. 3 C).
The editor L chain, λx, is also induced by cGvH. λx is 
known to bind MBP both as free L chain and in association 
with H chains (40, 41), including 56R (unpublished data). 
We tested the possibility that cGvH might induce λx-associ-
ated Abs by a Western blot of sera developed with a λx anti-
serum (Fig. 5 B). We were unable to detect λx in the serum 
of 56R/B6 mice or in nontransgenic B6 mice, but after initi-
ation of the cGvH, we found that λx levels in both 56R/B6 
and nontransgenic B6 mice rose rapidly and were maintained 
until day 60 (Fig. 5 B; not depicted for day 60). Expression of 
λx after cGvH was signifi  cantly higher in the 56R transgenic 
than in the nontransgenic B6, suggesting that this L chain is 
associated with the 56R H chain. Consistent with the ELISA 
data (Fig. 5 A), we also found increased levels of λ and κ; 
however, in 56R/B6, expression of those L chains did not 
increase to the same extent as λx (Fig. 5 B).
DISCUSSION
The 56R H chain transgene enhances the anti-DNA produc-
tion in cGvH (14, 15) and in the quasi-autoimmune B6 (30–
34 and unpublished data). This is unexpected because Abs 
with the 56R H chain in BALB/c are edited. DNA binding 
is either vetoed by L chains, such as Vκ21D (17) and λx (21, 
22), or DNA binding on the cell surface is diluted because 
more than one receptor is expressed (17, 23, 24). In this 
study, we show that editing can also be incomplete (Fig. 2). 
Editors were originally defi   ned in BALB/c transgenics, a 
strain that does not convert to autoimmunity even with an 
anti-DNA transgene. Most of the B cells from this mouse ex-
press the 56R H chain with Vκ21D, an L chain that vetoes 
DNA binding completely (17). In the B6 mouse, the L chain 
repertoire is reversed, very few 56R/Vκ21D combinations 
are found, and the majority of B cells express 56R H chain 
with incomplete editors, such as Vκ20 and Vκ38C (reference 
20, unpublished data, and Table III). We think that the dif-
ference lies in the tolerance threshold of the strain: BALB/c, 
the prototypic “healthy” strain, tolerates only completely 
  edited Abs, whereas B6, a lupus-susceptible strain (30–34), is 
more permissive. We show that the cGvH-induced auto-
immunity in 56R/B6 mice activates B cells using the incom-
plete editors Vκ20 and Vκ38C (Fig. 2 and Table I B). Thus, 
incomplete editing contributes to autoimmunity by deter-
mining an available repertoire that includes autoreactive B 
cells. In support of this idea is the fi  nding that 56R/B6 and 
the congenic 56R/Sle2/B6 (expressing the additional lupus 
susceptibility gene Sle2) spontaneously produce anti-DNAs 
that include 56R/Vκ20 Abs (unpublished data). Evidence 
for such a “lupus repertoire” is also found in lupus-aff  ected 
individuals (3, 4).
Incomplete editing is inevitable. The ability of certain L 
chains to edit is correlated with certain structural features of 
these L chains, in particular, a high frequency of Asp residues 
in or near the CDRs (17). Hence, we think editing may be 
the result of an interaction between the VH Arg residues and 
the VL Asp residues to interfere with the VH Arg interaction 
with DNA (38, 42, 43). However, editor Asps may not neu-
tralize every Arg and might account for residual anti-DNA 
activity (44). Similarly, not all Asps need to interact with Args 
and might be available for interactions with basic proteins 
such as MBP, as in the 56R/λx.
The incompletely edited Abs, such as 56R/Vκ20, retain 
activity for DNA and cardiolipin. This is thought to be a 
cross-reaction based on binding to a phosphate-containing 
moiety shared by both (45). But a novel source of polyreac-
tivity comes from binding activities that some editors confer 
upon an anti-DNA VH. In this case, polyreactivity is not be-
cause of cross-reactivity but because of alternate binding sites. 
Table IV.  κ/λ L chain double-expressing clones from fusion 10 wk after cGvH (Bm-12 into 56R/B6)
Clone no. 56R PCR Vκ(S)/J5 λ1 PCR λ2 PCR λx PCR IgM ELISA κ ELISA λ1,2,3 ELISA dsDNA ELISA 
[OD]
MBP ELISA 
[OD]
PS ELISA 
[OD]
30 + J5 +   +++ + 1.284 1.919 0.274
35 + J5 +   +++ + 1.669 2.154 0.536
41 + J5 +    ++ + 1.741 2.006 0.768
124 + J5 +   +++ + 1.361 1.846 0.842
57 +    +   +   + 0.979 0.36 0.904
59 -   +    ++ n.d. n.d. n.d.
n.d., not done.JEM VOL. 203, July 10, 2006  1769
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A relevant example has been described in which the 3H9 H 
chain gives diff  erent patterns of antinuclear antigens depend-
ing on the L chain with which it is associated (46). We con-
clude from these results that editor L chains are correlated 
with anti-self activity. J gene usage also seemed to play a role 
in binding some proteins, namely MBP, thyroglobulin, cyto-
chrome C, and histone, as shown for its relevance for Vκ20 
and Vκ38C in binding to dsDNA (Fig. 2, A and B). Al-
though polyreactivity can come about by the creation of dif-
ferent combining sites, it can also be due to enhanced 
cross-reactivity, as in the case of Vκ20.
 Receptor editing acts in B cells with autoreactive recep-
tors; hence, rearrangement persists and can produce isotypi-
cally included B cells as we have described in the 56R/BALB/c 
transgenic mouse. One of the two receptors (56R/λ1) is anti-
DNA (38), and the other is a 56R/κ editor (24). Such iso-
typically included κ/λ double-expressing B cells in 56R/
BALB/c are found in the MZ of the spleen (24) and in hy-
bridomas from LPS-activated fusions. Fusion panels gener-
ated after cGvH include clones that coexpressed λ1 and κ L 
chain and secrete anti-DNA Abs. In this study, none of the 
clones (Table IV) expressed λ1 L chain only. Therefore, we 
think the κ/λ B cell may represent a state of tolerance. In this 
sense, a B cell may have a self-reactive receptor and expres-
sion of two L chains may alter or reduce the affi   nity of the 
B cell to an antigen. Other examples of dual expression come 
from recent studies in 56R mice in which the κ locus has 
been knocked out. Hybridoma panels from these mice 
showed that the vast majority of the 56R/λ1 B cells coex-
pressed λx L chain, an effi   cient editor, and only very few 
have rearranged λ1 alone (47 and unpublished data), but 
these 56R/λ1 clones bound DNA even when λx L chain 
was coexpressed. cGvH appeared to activate these κ/λ double-
expressing B cells because we fi  nd anti-DNA Abs with λ1 in 
the serum in cGvH (Fig. 5 A). By single cell analysis we 
tested whether these κ/λ B cells may be in the MZ of 56R/
B6 mice and confi  rmed the existence of κ/λ-included B cells 
(Table III). Single cell analysis of MZ B cells also revealed in-
teresting properties that may act on the λ locus. All λ L chain 
rearrangements, whether out-of-frame or in-frame, were ac-
companied by a κ L chain, which was (except in one case) 
in-frame (Table III).
As discussed above, we think that DNA and/or MBP 
binding can result from incomplete editing. For example, the 
Asp-rich λx editor in association with H chains including 
56R binds MBP (40, 41, and unpublished data). The acidic 
property of λx to which we attribute the MBP activity is also 
a feature of κ editors, and these L chains might also confer 
MBP activity to 56R. And, as we show here, 56R with 
Vκ38C and Vκ20 also bound MBP as well as DNA and PS 
(Fig. 2, A and B) (28). Therefore, an incompletely edited Ab 
may have both Arg(s) and Asp(s) available for binding both to 
DNA and proteins.
During the cGvH reaction there was a change in the 
  percentages of MZ B cells, follicular B cells, and CD21–
CD23– B cells (Fig. 3 B). MZ B cells may have activated by 
alloreactive Bm-12 T cells, which in turn may have activated 
endogenous T cells of the 56R/B6 recipient. These T cells 
could give help to the diff  erentiation of plasma cells. This 
idea is consistent with recent fi  ndings that showed that MZ 
B cells, not follicular B cells, are potent activators of naive 
CD4+ T cells. MZ B cells migrate to T cell areas and diff  er-
entiate upon interaction with T cells into plasma cells (48). 
This could be the case in the cGvH reaction, and plasma cells 
found in the CD21–CD23– population might be a source of 
auto-Abs to DNA (Fig. 3 B, histograms). Support for this 
idea comes from features of 56R/Sle2/B6. Sle2 further in-
creases the tendency to autoimmunity of 56R/B6, and in 
56R/Sle2/B6, the MZ and the CD21–CD23– B cell popula-
tions are increased as compared with 56R/B6. These CD21–
CD23– B cells secreted auto-Abs of the IgMa allotype, the 
transgene-encoded allele, in culture (unpublished data). We 
also fi  nd Abs reactive to DNA expressing the H chain of 
the Iga allotype (Table I). Assuming that both Sle2 and cGvH 
enhance autoimmunity, we think that the increase of the 
CD21–CD23– cells in 56R/Sle2/B6 is analogous to the in-
crease of CD21–CD23– B cells in cGvH-induced autoim-
munity. The question remains whether partially edited κ and 
λ double positive B cells are able to move out of MZ to be-
come plasma cells.
Conclusions
Autoreactive and polyreactive Abs.  Here we present a 
  detailed description of the auto-Abs induced by cGvH. The 
study reveals the structural basis for autoreactivity of certain 
Abs and the origin of these auto-Abs.
Origin. Natural auto-Abs are found in abundance in both 
healthy and autoimmune individuals, and there is a vast and 
confusing literature on their origin, rationale, and implica-
tions for autoimmunity and immune protection (49). Our 
study answers these questions by showing that at least some 
if not all “natural” auto-Abs result from receptor editing. Of 
course, the abundance of these autoAbs in our model is in 
part because of the anti-DNA transgene. This produces an 
immature B cell population, most of which must be edited 
to survive. But even nontransgenics must have a substantial 
repertoire that is shaped by editing. Based on the mecha-
nisms that generate the immature VH repertoire, we esti-
mate that at least 50% of this repertoire is anti-DNA (50, 51). 
Thus, editing of this population will have a profound infl  u-
ence on the frequency of natural auto-Abs in the peripheral 
B cell repertoire.
Relevance. A question raised by natural auto-Abs is how to 
explain their presence in a self-tolerant individual. This di-
lemma is usually explained by invoking affi   nity diff  erences; 
i.e., natural auto-Abs are low affi   nity anti-self and are ig-
nored by tolerance mechanisms (52). But the question re-
mains: Why is there a large abundance of these auto-Abs? 
The only explanation is positive selection (53) of this popula-
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These roles range from housekeeping Abs to stimulators of 
the repertoire to anti-virus Abs (49). If indeed natural auto-
Abs are important in normal immunity, their existence in the 
repertoire can be understood. It has been shown that the B 
cell repertoire that is induced by the cGvH is not random but 
a selective process and requires B cell receptor cross-linking 
(12) and is supported by the involvement of endogenous T 
cells (as seen in this study [Fig. 4] and by others [37]). In ad-
dition, certain edited auto-Abs appear to be selected as sug-
gested by diff  erences in the repertoire of editors between 
strains; for example, the distribution of editors in B6 as com-
pared with BALB/c.
Implications. We show here that the peripheral repertoire 
is shaped by receptor editing and selection. Negative se-
lection can continue to act on edited B cells if they retain 
self-reactivity after the initial editing event. In this sense,
a healthy BALB/c mouse may only tolerate perfectly   edited, 
nonautoreactive B cells. Other strains may be more permissive 
and allow incompletely edited B cells to enter the periphery. 
The ability to regulate this population may determine lupus 
susceptibility by supplying the peripheral B cell population 
with the precursors to pathogenic auto-Abs. That these B 
cells are involved in the onset of disease is demonstrated by 
these fi  ndings.
MATERIALS AND METHODS
Mice. The generation of site-directed 3H9/56R knock-in mice has been 
described previously (13, 17). The 3H9/56R was backcrossed onto the 
C57/BL6 background for 14 generations to engender 3H9/56R/B6. The 
3H9/56R transgene was determined by PCR amplifi  cation of tail DNA (16, 
17). B6 and coisogenic Bm-12 (B6.C-H2bm12/KhEg) mice were obtained 
from The Jackson Laboratory. All mice were maintained in our mouse col-
ony at the University of Chicago. All animal care and procedures were con-
ducted in accordance with the Animal Welfare Act.
cGvH. Mice were 2–8 mo old at time of cGvH initiation. All cGvH experi-
ments for fl  ow cytometry, serum data, and the fusion experiment at 10 wk 
after cGvH were performed with 107 Bm-12 (for cGvH) or B6 (for controls) 
CD4+ T cells. For the fusion at 4 wk, cGvH was performed as described 
previously (9). In brief, recipient mice were injected i.p. with Bm-12 (for 
cGvH) or B6 (for controls) splenocytes prepared using standard techniques, 
or with 107 CD4+ T cells (purity >96%) purifi  ed using the CD4 (L3T4) 
MicroBead MACS system (Miltenyi Biotec). Experimental mice were bled 
before onset of cGvH and weekly thereafter.
Flow cytometry. Before staining, cells were preincubated with excess mouse 
anti–Fcγ III/II R (2.4G2; BD Biosciences) to block Fc receptors. Dead 
cells were excluded by propidium iodide staining (0.33 μg/ml). The fol-
lowing mAbs were used for staining: RA3-6B2-APC (anti-B220), 145-
2C11-FITC (anti-CD3), 145-2C11-APC (anti-CD3), 30-F1-biotin 
(anti-CD24), L3T4-PE (anti-CD4), Jo2-PE (anti-CD95), H1.2F3-FITC 
(anti-CD69), AF6-78-PE (anti-IgM allotype b), AMS9.1-FITC (anti-IgD 
allotype a), 217-170-biotin (anti-IgD allotype b), R26-46-FITC (anti-
λ1,2,3), H139.52.1-PE (anti-κ), 7G6-FITC (anti-CD21), B3B4-PE (anti-
CD23), 281-2-PE (anti-CD138), and 281-2-biotin (anti-CD138, used in 
Fig. 3 B only; all from BD Biosciences); GL1-FITC (anti-CD86), 
M5/114.15.2-FITC (anti–MHC II), 7E.17G9-PE (anti-ICOS), 37.51-APC 
(anti-CD28), IM7-APC (anti-CD44), C363.16A-PE (anti-CD45RB), and 
MEL-14-FITC (anti-CD62L; all from eBioscience); and RS3.1-Alexa 488 
(anti-IgM allotype a, own hybridoma, conjugated to Alexa 488; Invitrogen) 
and anti–IgM-FITC (SouthernBiotech). Detection of biotinylated Abs 
was done using streptavidin-FITC, streptavidin-PE, or streptavidin-PE-Cy5 
(all from BD Biosciences). Data were generated on a FACSCanto (BD 
  Biosciences) and analyzed using FlowJo software.
Hybridomas. 3H9/56R/B6 mice were injected with Bm-12 splenocytes 
(fusion 4 wk after injection as described previously [14, 15]) or with Bm-12 
CD4+ T cells (fusion 10 wk after injection). Hybridomas were generated in 
the Monoclonal Antibody Facility of the University of Chicago as described 
previously (21). In brief, spleen cells from cGvH mice were fused without 
further manipulation to Sp2/0 myeloma cells. Hybridomas were plated at 
limiting dilution, wells bearing single colonies on 96-well plates were ex-
panded, and hybridomas were grown 90% confl  uent in six-well plates for 
ELISA assays.
Antigens. dsDNA (Vector Laboratories) was biotinylated and diluted 
1 μg/ml PBS. PS was dissolved in chloroform (90%) and methanol (10%; 
10  μg/ml). Human MBP from postmortal brain (RDI), total histone 
(Roche), β-galactosidase from Escherichia coli, cyochrome C from bovine 
heart, thyroglobulin from bovine thyroid, and human insulin (all Sigma-
  Aldrich) were dissolved in 10 μg/ml PBS.
Auto-Abs in serum. Unless otherwise indicated, sera were diluted at 1:180 
in the appropriate blocking buff  er of the ELISA assay. Immulon 2 HBX was 
used for PS, and Immulon 4 HBX ELISA plates were used for all other 
ELISA assays (Thermo-Lab Systems).
DsDNA. Anti-dsDNA Abs were detected as described previously (19). 
Plates were coated with 10 μg avidin D (Vector Laboratories) in PBS at 4°C, 
blocked in PBS with 1% BSA at 37°C for 2 h, and washed with PBS with 
0.05% Tween (PBS-T). Biotinylated dsDNA was bound to avidin-coated 
plates at 37°C for 1.5 h. Sera were applied, plates were washed three times, 
and DNA serum complexes were detected with anti–mouse IgM-Ap, IgG-
AP, κ-AP, or λ-AP (all from SouthernBiotech). After absorption for 60 min, 
plates were washed and the retaining anti-dsDNA IgM, IgG, κ, or λ Abs were 
quantifi  ed using AP substrate (Sigma-Aldrich). The OD was determined 
at 450 nm.
PS. Anti-PS Abs were detected as described previously (45). Plates were 
coated with PS (Sigma-Aldrich) in 100% EtOH, dried, and blocked in 0.1% 
gelatin/1% BSA at 37°C for 2 h. Plates were washed with PBS. Sera were 
applied, plates were washed, and PS serum complexes were detected as 
  described for dsDNA binding.
MBP. Anti-MBP Abs were detected as described previously (40). Plates 
were coated with 10 μg human MBP in PBS at 4°C overnight and blocked 
in 0.5% casein at 37°C for 2 h. Plates were washed with PBS-T. Diluted sera 
were applied, plates were washed, and MBP serum complexes were detected 
as described for dsDNA binding.
Auto-Abs in hybridoma supernatants. Supernatants were tested for 
  dsDNA and PS binding as described above for serum. Blocking buff  er 
for MBP and all other protein binding assays contained 8% casein in PBS. 
Supernatants from fusions were tested for binding to dsDNA, PS, and to 
proteins MBP, thyroglobuline, cytochrome C, histone, β-galactosidase, and 
insulin. The OD405 of the binding assays was normalized based on the Ig 
concentration of each supernatant.
Isotype and Ig concentration in hybridoma supernatants. Isotype and 
concentration in culture supernatants were determined as described previ-
ously (47). In brief, plates were coated with unconjugated anti–mouse Ig, 
supernatants from hybridomas were added, and binding was detected with 
goat anti–IgM-AP or anti–IgG-AP and developed with AP substrate. The Ig 
concentration was determined by comparing samples to a standard curve 
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PCRs on hybridoma DNA. Genomic DNA was purifi  ed from individual 
hybrids. 150 pg DNA was used in each reaction. Primers and conditions for 
H and L chain PCR assays have been detailed previously (13, 47, 54). The 
presence of 3H9/56R H chain transgene was identifi   ed by PCR using 
  primers complementary to the 3H9 H chain leader exon and the CDR3 
  sequence (16), or with a 56R CDR3 reverse primer (the complement of the 
56R/CDR3 primer described above) and the JHCH primer. The JHCH 
primer binds to a site between JH4 and CH (55). This primer amplifi  es 
truncated or replaced 3H9 VH genes because both occur at the embedded 
heptamer 5′ of CDR3.
For typing of κ L chain rearrangements, Vκ-specifi  c forward primers 
(Vκ12-13, Vκ20, Vκ21D, and Vκ38C) and Vκ(S) (39) or L5 (56) forward 
primers were used under conditions described previously (17). The Vκ(S) 
PCR primer should amplify 70% and the L5 primer should amplify  60% 
of Vκ genes. Using Jκ2 or Jκ5 reverse Jκ primers (57), the size of the PCR 
product corresponds to the Jκ segment participating in the rearrangement 
event as described previously (54). To determine editor rearrangements, 
PCRs were performed in 1× buff  er II (PerkinElmer) with a fi  nal concen-
tration of 200 μM of each dNTP (Boehringer), 50 pmol of each primer, 
1.5 mM MgCl2, and 1 U of AmpliTaq Gold (PerkinElmer). Selected PCR 
products were sequenced using primers for Vκ20, Vκ21D, and Vκ38C as 
indicated in Results.
Single cell sorting, cDNA synthesis, and PCR. Single cell PCR was 
performed as described previously (3). MZ B cells B220+CD21intCD23high 
from one 56R/B6 mouse were sorted on a FACSVantage (Becton Dickinson) 
into 96-well PCR plates containing 4 μl lysis solution (0.5× PBS containing 
10 mM dithiothreitol, 8 U RNAsin [Promega], and 0.4 U 5′-3′ Prime RNase 
Inhibitor [Eppendorf]) and were immediately frozen on dry ice. All samples 
were stored at −70°C. The cDNA was synthesized in a total volume of 14 μl 
in the original 96-well PCR plate. RNA from single cells was reverse tran-
scribed at 37°C for 55 min with 150 ng random hexamer primer (pd(N)6; GE 
Healthcare), 0.5 μl dNTP mix (10 mM each), 1 μl of 0.1 M dithiothreitol, 
0.5% (vol/vol) Nonidet P-40, RNase inhibitors (4 U RNasin and 6 U Prime 
RNase inhibitor), and 50 U Superscript III reverse transcriptase (Invitrogen). 
Ig gene rearrangement was tested using the degenerate primer Vκ(S) (39) with 
nested Cκ reverse primers, specifi  c nested primers for Vκ21D and Vκ38C 
with nested Cκ reverse primers (for primers see reference 20), primers for the 
56R H chain transgene (20), and primers for Vλ (designed as follows: Vλ1/2 ext, 
5′caggctgttgtgactcaggaatct3′; Vλ1/2int, 5′cagtcacactcacttgtcgctcaa3′; Cλext, 
5′gcacgggacaaactcttctccaca3′; Cλint, 5′gagctcttcagaggaaggtggaaa-3′). Products 
were amplifi  ed by nested PCR (for Vκ(S)Cκ “semi-nested PCR”) in 40-μl 
  reactions containing 20 pM primers and 1.2 U HotStar Taq DNA polymerase 
(QIAGEN). The PCR conditions were as   follows: Denaturation for 4 min at 
94°C, followed by 30 s at 94°C and 30 s at 55°C (for Vκ21D, Vκ38C, and 
56R H chain), or at 50°C (for Vκ(S) and Vλ1/2) and 55 s (fi  rst PCR) or 45 s 
(nested PCR) at 72°C for 50 cycles. Elongation was allowed for 10 min at 
72°C. As a template, 2 μl cDNA was used for the fi  rst PCR and 3 μl of the 
fi   rst PCR product was used for the nested PCR. PCR products were 
  sequenced using primers for Vκ20, Vκ21D, Vκ38C, Vκ(S) and Cκ, and Vλ1/2 
and Cλ as   indicated in Results.
Western blot. Serum samples were diluted to 1:100 for detection of λ and 
1:2,000 for detection of κ L chain in Tris- and SDS-containing buff  er. 
Proteins were denatured with β-ME and boiled for 5 min. Proteins were 
resolved on a 12% SDS page and transferred to a PVDF membrane 
(Bio-Rad Laboratories) at 100 mV, 500 mA. After blocking for 2 h with 
4% milk in PBS-T, the blot was probed at 4°C overnight with a rabbit 
anti–mouse Vλx polyclonal Ab (22) or with a horseradish peroxidase–
  labeled goat anti–mouse Vκ or Vλ1,2,3 polyclonal Abs (both Southern-
Biotech) in 1% milk in PBS-T. Membranes were washed three times at 
room temperature with PBS-T. For λx, membrane was incubated with 
horseradish peroxidase–conjugated goat anti–rabbit IgG (Bio-Rad Laboratories) 
for 2 h in 1% milk in PBS-T. Membranes for λx, λ1, and k were developed 
using ECL reagent.
Statistics. Statistical signifi  cance was determined using Anova Single Factor 
Test for analysis of ELISAs. Anova Single Factor Test is appropriate for multi-
ple statistical comparisons on a single dataset. Numbers in fi  gures give the actual 
p-value determined by this test (Fig. 2 B). For all other ELISA assays on single 
clones, the SEM was determined for triple repeats (Fig. 2 A) and on   serum 
from the indicated number of mice in each group (Figs. 1 and 5 A).
Online supplemental material. Online supplemental material gives 
greater details about fusion 4 wk after cGvH, fusion 10 wk after cGvH, and 
single cell analysis of MZ B cells isolated from a 56R/B6 mouse. Figs. S1 
and S2 and Tables S1–S3 are available at http://www.jem.org/cgi/content/
full/jem.20060075/DC1.
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